Pressure BioSciences, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Subsequent Events (Details Narrative)

Subsequent Events (Details Narrative)															1 Months Ended		12 Months Ended
Subsequent Events (Details Narrative)	Mar. 21, 2017 USD ($) shares	Mar. 16, 2017 $ / shares shares	Mar. 14, 2017 USD ($) shares	Mar. 02, 2017 USD ($)	Feb. 15, 2017 USD ($) shares	Feb. 06, 2017 USD ($)	Jan. 31, 2017 USD ($)	Jan. 17, 2017 USD ($) Integer $ / shares shares	Jan. 06, 2017 USD ($) shares	Aug. 28, 2015 USD ($)	May 29, 2015 USD ($)	Mar. 17, 2015 USD ($)	Jan. 29, 2015 USD ($)	Jan. 15, 2015 USD ($)	Feb. 28, 2017 USD ($) shares	Jan. 31, 2017 USD ($)	Dec. 31, 2016 USD ($)	Dec. 31, 2015 USD ($)
Proceeds from convertible debt																	$ 2,105,420	$ 5,558,537
Merchant Agreement [Member]
Debt instrument, monthly allotments										$ 2,560	$ 1,098	$ 559	$ 1,985	$ 744
Subsequent Event [Member]
Number of restricted common stock issued, shares \| shares									50,000
Payment of debt							$ 34,000
Number of restricted common stock issued									$ 10,000
Debt instrument, monthly allotments								$ 25,000
Number of allotments \| Integer								3
Subsequent Event [Member] \| Months 1-3 [Member]
Warrant exercise price \| $ / shares								$ 0.40
Number of warrants issued \| shares								100,000
Subsequent Event [Member] \| Months 4-6 [Member]
Warrant exercise price \| $ / shares								$ 0.60
Number of warrants issued \| shares								125,000
Subsequent Event [Member] \| Months 7-9 [Member]
Warrant exercise price \| $ / shares								$ 0.80
Number of warrants issued \| shares								125,000
Subsequent Event [Member] \| Months 10-12 [Member]
Warrant exercise price \| $ / shares								$ 1.00
Number of warrants issued \| shares								150,000
Subsequent Event [Member] \| October Revolving Note [Member]
Proceeds from loan															$ 500,000	$ 250,000
Number of warrants to purchase common stock \| shares															1,875,000
Subsequent Event [Member] \| Merchant Agreement [Member]
Proceeds from loan				$ 75,000		$ 125,000
Fee paid for loan						1,250
Payment of debt						$ 16,180
Subsequent Event [Member] \| Privately-Held Investment Firm [Member]
Loan interest rate			10.00%
Original issue of discount percentage			10.00%
Number of restricted common stock issued, shares \| shares			250,000
Subsequent Event [Member] \| Privately-Held Investment Firm [Member] \| Non Convertible Loan [Member]
Proceeds from convertible debt			$ 250,000
Subsequent Event [Member] \| Two Accredited Investors [Member]
Loan interest rate					10.00%
Number of restricted common stock issued, shares \| shares					170,000
Subsequent Event [Member] \| Two Accredited Investors [Member] \| Non Convertible Loan [Member]
Proceeds from convertible debt					$ 110,000
Subsequent Event [Member] \| Incentive Stock Options [Member] \| Employees [Member]
Common stock, shares available for future grant to employees \| shares		660,000
Stock option exercise price \| $ / shares		$ 0.28
Stock option expected term		10 years
Subsequent Event [Member] \| Incentive Stock Options [Member] \| Officers, Consultants and Directors [Member]
Common stock, shares available for future grant to employees \| shares		1,855,000
Subsequent Event [Member] \| Restricted Stock [Member]
Warrant exercise price \| $ / shares								$ 0.40
Subsequent Event [Member] \| Accredited Investor [Member]
Proceeds from non convertible debt	$ 170,000
Loan interest rate	10.00%
Original issue of discount percentage	10.00%
Number of restricted common stock issued, shares \| shares	170,000